Screener / SEC EDGAR /CIK 0001585364 /10-K filed Feb 26, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Pharmaceuticals

PERRIGO Co plc PRGO

Compare with peers Embed

PRGO among the 162 companies we cover

Where it stands · the better end on the right. The band holds the middle half; the line is the median.

All 162
Sales growth
+4.8%+20.2%
-2.8%143rd of 155 · median +10.5%
Net margin
-4.1%15.3%
-43.3%137th of 154 · median 6.8%
Return on equity
-5.2%18.5%
-72.5%137th of 144 · median 9.2%
Free cash flow margin
2.3%19.2%
4.1%100th of 145 · median 10.0%
Debt / equity (less is better)
1.160.42
1.3590th of 108 · median 0.69

PRGO and 9 peers, year by year

The 9 Health care companies closest to PRGO in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

Choose the peers

Health care companies (up to 9):

Each company's latest fiscal year
CompanyYearRevenueSales growthGross marginOperating marginNet marginFCF marginReturn on equityDebt / equity
PRGO PERRIGO Co plc FY2025 $4.3B−2.8%35.1%−26.4%−33.5%3.4%−48.6%1.24
ALGN Align Technology FY2025 $4.0B+0.9%67.2%13.5%10.2%12.2%10.1%-
MTD Mettler Toledo FY2025 $4.0B+4.0%59.4%-21.6%21.1%n/mn/m
CRL Charles River Laboratories FY2025 $4.0B−0.9%-0.6%−3.6%12.9%−4.6%0.68
COO Cooper Companies FY2025 $4.1B+5.1%65.5%16.7%9.2%10.6%4.6%0.30
NBIX Neurocrine Biosciences Inc FY2025 $2.9B+21.4%-21.6%16.7%26.2%14.7%-
BMRN Biomarin Pharmaceutical Inc FY2025 $3.2B+12.9%-12.7%10.8%22.5%5.7%0.10
ILMN Illumina, Inc. FY2025 $4.3B−0.7%66.1%18.6%19.6%21.4%31.2%0.73
XRAY DENTSPLY SIRONA Inc. FY2025 $3.7B−3.0%50.0%−11.5%−16.2%2.8%−44.7%1.76
IDXX Idexx Laboratories FY2025 $4.3B+10.4%61.8%31.6%24.6%24.6%66.0%0.28

Each company, year by year

Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2016 to FY2025 · 10-K XBRL

PRGOPERRIGO Co plc
FY2016 revenue $5.3BFY2017 revenue $4.9BFY2018 revenue $4.7BFY2019 revenue $3.9BFY2020 revenue $4.1BFY2021 revenue $4.1BFY2022 revenue $4.5BFY2023 revenue $4.7BFY2024 revenue $4.4BFY2025 revenue $4.3B FY2016 net margin −76.0%FY2017 net margin 2.4%FY2018 net margin 2.8%FY2019 net margin 3.8%FY2020 net margin −4.0%FY2021 net margin −1.7%FY2022 net margin −3.2%FY2023 net margin −0.3%FY2024 net margin −3.9%FY2025 net margin −33.5% FY2016FY2025
Revenue$4.3B Growth−2.8% Net margin−33.5%
ALGNAlign Technology
FY2016 revenue $1.1BFY2017 revenue $1.5BFY2018 revenue $2.0BFY2019 revenue $2.4BFY2020 revenue $2.5BFY2021 revenue $4.0BFY2022 revenue $3.7BFY2023 revenue $3.9BFY2024 revenue $4.0BFY2025 revenue $4.0B FY2016 net margin 17.6%FY2017 net margin 15.7%FY2018 net margin 20.4%FY2019 net margin 18.4%FY2020 net margin 71.8%FY2021 net margin 19.5%FY2022 net margin 9.7%FY2023 net margin 11.5%FY2024 net margin 10.5%FY2025 net margin 10.2% FY2016FY2025
Revenue$4.0B Growth+0.9% Net margin10.2%
MTDMettler Toledo
FY2016 revenue $2.5BFY2017 revenue $2.7BFY2018 revenue $2.9BFY2019 revenue $3.0BFY2020 revenue $3.1BFY2021 revenue $3.7BFY2022 revenue $3.9BFY2023 revenue $3.8BFY2024 revenue $3.9BFY2025 revenue $4.0B FY2016 net margin 15.3%FY2017 net margin 13.8%FY2018 net margin 17.5%FY2019 net margin 18.6%FY2020 net margin 19.5%FY2021 net margin 20.7%FY2022 net margin 22.3%FY2023 net margin 20.8%FY2024 net margin 22.3%FY2025 net margin 21.6% FY2016FY2025
Revenue$4.0B Growth+4.0% Net margin21.6%
CRLCharles River Laboratories
FY2016 revenue $1.7BFY2017 revenue $1.9BFY2018 revenue $2.3BFY2019 revenue $2.6BFY2020 revenue $2.9BFY2021 revenue $3.5BFY2022 revenue $4.0BFY2023 revenue $4.1BFY2024 revenue $4.0BFY2025 revenue $4.0B FY2016 net margin 9.2%FY2017 net margin 6.6%FY2018 net margin 10.0%FY2019 net margin 9.6%FY2020 net margin 12.5%FY2021 net margin 11.0%FY2022 net margin 12.2%FY2023 net margin 11.5%FY2024 net margin 0.5%FY2025 net margin −3.6% FY2016FY2025
Revenue$4.0B Growth−0.9% Net margin−3.6%
COOCooper Companies
FY2016 revenue $2.0BFY2017 revenue $2.1BFY2018 revenue $2.5BFY2019 revenue $2.7BFY2020 revenue $2.4BFY2021 revenue $2.9BFY2022 revenue $3.3BFY2023 revenue $3.6BFY2024 revenue $3.9BFY2025 revenue $4.1B FY2016 net margin 13.9%FY2017 net margin 17.4%FY2018 net margin 5.5%FY2019 net margin 17.6%FY2020 net margin 9.8%FY2021 net margin 100.8%FY2022 net margin 11.7%FY2023 net margin 8.2%FY2024 net margin 10.1%FY2025 net margin 9.2% FY2016FY2025
Revenue$4.1B Growth+5.1% Net margin9.2%
NBIXNeurocrine Biosciences Inc
FY2016 revenue $15.0MFY2017 revenue $161.6MFY2018 revenue $451.2MFY2019 revenue $788.1MFY2020 revenue $1.0BFY2021 revenue $1.1BFY2022 revenue $1.5BFY2023 revenue $1.9BFY2024 revenue $2.4BFY2025 revenue $2.9B FY2016 net margin −940.6%FY2017 net margin −88.2%FY2018 net margin 4.7%FY2019 net margin 4.7%FY2020 net margin 38.9%FY2021 net margin 7.9%FY2022 net margin 10.4%FY2023 net margin 13.2%FY2024 net margin 14.5%FY2025 net margin 16.7% FY2016FY2025
Revenue$2.9B Growth+21.4% Net margin16.7%
BMRNBiomarin Pharmaceutical Inc
FY2016 revenue $1.1BFY2017 revenue $1.3BFY2018 revenue $1.5BFY2019 revenue $1.7BFY2020 revenue $1.9BFY2021 revenue $1.8BFY2022 revenue $2.1BFY2023 revenue $2.4BFY2024 revenue $2.9BFY2025 revenue $3.2B FY2016 net margin −56.4%FY2017 net margin −8.9%FY2018 net margin −5.2%FY2019 net margin −1.4%FY2020 net margin 45.9%FY2021 net margin −3.5%FY2022 net margin 6.8%FY2023 net margin 6.9%FY2024 net margin 15.0%FY2025 net margin 10.8% FY2016FY2025
Revenue$3.2B Growth+12.9% Net margin10.8%
ILMNIllumina, Inc.
FY2016 revenue $2.4BFY2017 revenue $2.8BFY2018 revenue $3.3BFY2019 revenue $3.5BFY2020 revenue $3.2BFY2021 revenue $4.5BFY2022 revenue $4.6BFY2023 revenue $4.5BFY2024 revenue $4.4BFY2025 revenue $4.3B FY2016 net margin 19.3%FY2017 net margin 26.4%FY2018 net margin 24.8%FY2019 net margin 28.3%FY2020 net margin 20.3%FY2021 net margin 16.8%FY2022 net margin −96.1%FY2023 net margin −25.8%FY2024 net margin −28.0%FY2025 net margin 19.6% FY2016FY2025
Revenue$4.3B Growth−0.7% Net margin19.6%
XRAYDENTSPLY SIRONA Inc.
FY2016 revenue $3.7BFY2017 revenue $4.0BFY2018 revenue $4.0BFY2019 revenue $4.0BFY2020 revenue $3.3BFY2021 revenue $4.2BFY2022 revenue $3.9BFY2023 revenue $4.0BFY2024 revenue $3.8BFY2025 revenue $3.7B FY2016 net margin 11.5%FY2017 net margin −38.8%FY2018 net margin −25.4%FY2019 net margin 6.4%FY2020 net margin −2.2%FY2021 net margin 9.7%FY2022 net margin −24.2%FY2023 net margin −3.3%FY2024 net margin −24.0%FY2025 net margin −16.2% FY2016FY2025
Revenue$3.7B Growth−3.0% Net margin−16.2%
IDXXIdexx Laboratories
FY2016 revenue $1.8BFY2017 revenue $2.0BFY2018 revenue $2.2BFY2019 revenue $2.4BFY2020 revenue $2.7BFY2021 revenue $3.2BFY2022 revenue $3.4BFY2023 revenue $3.7BFY2024 revenue $3.9BFY2025 revenue $4.3B FY2016 net margin 12.5%FY2017 net margin 13.4%FY2018 net margin 17.0%FY2019 net margin 17.8%FY2020 net margin 21.5%FY2021 net margin 23.2%FY2022 net margin 20.2%FY2023 net margin 23.1%FY2024 net margin 22.8%FY2025 net margin 24.6% FY2016FY2025
Revenue$4.3B Growth+10.4% Net margin24.6%

Who rewrote the most

Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before

Risk FactorsMD&AEach company's latest 10-K, so the dates differ. A company that rewrote much may have reorganized the text.

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

100 500 2000 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ALGN: $1.1B, $1.5B, $2.0B, $2.4B, $2.5B, $4.0B, $3.7B, $3.9B, $4.0B, $4.0B ALGN MTD: $2.5B, $2.7B, $2.9B, $3.0B, $3.1B, $3.7B, $3.9B, $3.8B, $3.9B, $4.0B MTD CRL: $1.7B, $1.9B, $2.3B, $2.6B, $2.9B, $3.5B, $4.0B, $4.1B, $4.0B, $4.0B CRL COO: $2.0B, $2.1B, $2.5B, $2.7B, $2.4B, $2.9B, $3.3B, $3.6B, $3.9B, $4.1B COO NBIX: $15.0M, $161.6M, $451.2M, $788.1M, $1.0B, $1.1B, $1.5B, $1.9B, $2.4B, $2.9B NBIX BMRN: $1.1B, $1.3B, $1.5B, $1.7B, $1.9B, $1.8B, $2.1B, $2.4B, $2.9B, $3.2B BMRN ILMN: $2.4B, $2.8B, $3.3B, $3.5B, $3.2B, $4.5B, $4.6B, $4.5B, $4.4B, $4.3B ILMN XRAY: $3.7B, $4.0B, $4.0B, $4.0B, $3.3B, $4.2B, $3.9B, $4.0B, $3.8B, $3.7B XRAY IDXX: $1.8B, $2.0B, $2.2B, $2.4B, $2.7B, $3.2B, $3.4B, $3.7B, $3.9B, $4.3B IDXX PRGO: $5.3B, $4.9B, $4.7B, $3.9B, $4.1B, $4.1B, $4.5B, $4.7B, $4.4B, $4.3B PRGO
PRGO is the bold green line; each peer has its own colour and dash, named at the line's end. Each company's first year in the window is 100, on a log scale: a line twice as high has doubled. A gap is a year with no number. PRGO: the line is cut where a later 10-K restates the year before (a spin-off or a merger), so the two years are not the same company.

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

−24.1% +978% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ALGN: +27.7%, +36.4%, +33.5%, +22.4%, +2.7%, +59.9%, −5.5%, +3.4%, +3.5%, +0.9% ALGN MTD: +4.7%, +8.6%, +7.7%, +2.5%, +2.5%, +20.5%, +5.4%, −3.4%, +2.2%, +4.0% MTD CRL: +23.3%, +10.5%, +22.0%, +15.7%, +11.5%, +21.1%, +12.3%, +3.9%, −1.9%, −0.9% CRL COO: +9.4%, +8.8%, +18.4%, +4.8%, −8.4%, +20.2%, +13.2%, +8.6%, +8.4%, +5.1% COO NBIX: −24.1%, +978%, +179%, +74.7%, +32.7%, +8.4%, +31.3%, +26.8%, +24.8%, +21.4% NBIX BMRN: +25.5%, +17.6%, +13.5%, +14.3%, +9.2%, −0.8%, +13.5%, +15.4%, +18.0%, +12.9% BMRN ILMN: +8.0%, +14.8%, +21.1%, +6.3%, −8.6%, +39.7%, +1.3%, −1.7%, −2.9%, −0.7% ILMN XRAY: +40.0%, +6.6%, −0.2%, +1.1%, −17.0%, +26.7%, −7.3%, +1.1%, −4.3%, −3.0% XRAY IDXX: +10.8%, +10.9%, +12.4%, +8.8%, +12.5%, +18.8%, +4.7%, +8.7%, +6.5%, +10.4% IDXX PRGO: -, −6.3%, −4.3%, +2.2%, +5.6%, +1.2%, +7.6%, +4.6%, −6.1%, −2.8% PRGO
PRGO is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −24.1% to +978%. A gap is a year with no number. A ring marks where a line starts: PRGO has no earlier 10-K here.

Gross margin, FY2016 to FY2025

Gross profit / revenue.

32.7% 75.8% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ALGN: 75.5%, 75.8%, 73.6%, 72.5%, 71.3%, 74.3%, 70.5%, 70.1%, 70.0%, 67.2% ALGN MTD: 57.3%, 57.8%, 57.4%, 57.9%, 58.4%, 58.4%, 58.9%, 59.2%, 60.1%, 59.4% MTD COO: 59.6%, 63.9%, 64.4%, 66.2%, 63.1%, 66.9%, 64.7%, 65.6%, 66.6%, 65.5% COO ILMN: 69.5%, 66.4%, 69.0%, 69.6%, 68.0%, 69.7%, 64.8%, 60.9%, 65.4%, 66.1% ILMN XRAY: 53.4%, 54.8%, 51.9%, 53.8%, 49.6%, 55.5%, 54.2%, 52.6%, 51.6%, 50.0% XRAY IDXX: 54.9%, 55.7%, 56.1%, 56.7%, 58.0%, 58.8%, 59.5%, 59.8%, 61.0%, 61.8% IDXX PRGO: 38.9%, 40.0%, 38.7%, 37.0%, 36.6%, 34.2%, 32.7%, 36.1%, 35.3%, 35.1% PRGO
PRGO is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 32.7% to 75.8%. A gap is a year with no number.

Operating margin, FY2016 to FY2025

Operating income / revenue.

−982.5% 31.6% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ALGN: 23.1%, 24.0%, 23.7%, 22.5%, 15.7%, 24.7%, 17.2%, 16.7%, 15.2%, 13.5% ALGN CRL: 14.1%, 15.5%, 14.6%, 13.4%, 14.8%, 16.7%, 16.4%, 14.9%, 5.6%, 0.6% CRL COO: 16.5%, 20.1%, 15.9%, 20.6%, 12.8%, 17.3%, 15.3%, 14.8%, 18.1%, 16.7% COO NBIX: −982.5%, −81.3%, 8.2%, 9.2%, 15.6%, 9.0%, 16.7%, 13.3%, 24.2%, 21.6% NBIX BMRN: −71.9%, −1.1%, −8.3%, −5.9%, −2.3%, −4.5%, 7.7%, 7.7%, 17.0%, 12.7% BMRN ILMN: 24.5%, 22.0%, 26.5%, 27.8%, 17.9%, −2.7%, −91.2%, −23.7%, −19.1%, 18.6% ILMN XRAY: 12.1%, −39.1%, −24.0%, 8.8%, −0.1%, 14.4%, −23.9%, −2.1%, −23.2%, −11.5% XRAY IDXX: 19.7%, 21.0%, 22.2%, 23.0%, 25.7%, 29.0%, 26.7%, 30.0%, 29.0%, 31.6% IDXX PRGO: −37.9%, 12.1%, 5.0%, 4.5%, 6.5%, 9.9%, 1.8%, 3.3%, 2.6%, −26.4% PRGO
PRGO is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −982.5% to 31.6%. A gap is a year with no number.

Net margin, FY2016 to FY2025

Net income / revenue.

−940.6% 100.8% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ALGN: 17.6%, 15.7%, 20.4%, 18.4%, 71.8%, 19.5%, 9.7%, 11.5%, 10.5%, 10.2% ALGN MTD: 15.3%, 13.8%, 17.5%, 18.6%, 19.5%, 20.7%, 22.3%, 20.8%, 22.3%, 21.6% MTD CRL: 9.2%, 6.6%, 10.0%, 9.6%, 12.5%, 11.0%, 12.2%, 11.5%, 0.5%, −3.6% CRL COO: 13.9%, 17.4%, 5.5%, 17.6%, 9.8%, 100.8%, 11.7%, 8.2%, 10.1%, 9.2% COO NBIX: −940.6%, −88.2%, 4.7%, 4.7%, 38.9%, 7.9%, 10.4%, 13.2%, 14.5%, 16.7% NBIX BMRN: −56.4%, −8.9%, −5.2%, −1.4%, 45.9%, −3.5%, 6.8%, 6.9%, 15.0%, 10.8% BMRN ILMN: 19.3%, 26.4%, 24.8%, 28.3%, 20.3%, 16.8%, −96.1%, −25.8%, −28.0%, 19.6% ILMN XRAY: 11.5%, −38.8%, −25.4%, 6.4%, −2.2%, 9.7%, −24.2%, −3.3%, −24.0%, −16.2% XRAY IDXX: 12.5%, 13.4%, 17.0%, 17.8%, 21.5%, 23.2%, 20.2%, 23.1%, 22.8%, 24.6% IDXX PRGO: −76.0%, 2.4%, 2.8%, 3.8%, −4.0%, −1.7%, −3.2%, −0.3%, −3.9%, −33.5% PRGO
PRGO is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −940.6% to 100.8%. A gap is a year with no number.

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

−$376.2M $1.1B FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ALGN: $177.1M, $242.8M, $331.4M, $597.6M, $507.3M, $771.4M, $276.8M, $608.1M, $622.7M, $490.8M ALGN MTD: $336.8M, $388.9M, $422.3M, $506.1M, $632.2M, $801.2M, $737.8M, $860.6M, $864.4M, $848.6M MTD CRL: $261.6M, $235.6M, $301.1M, $340.4M, $380.0M, $532.0M, $294.9M, $365.4M, $501.6M, $518.5M CRL COO: $357.0M, $466.4M, $475.3M, $421.1M, $176.2M, $524.2M, $450.4M, $215.0M, $288.1M, $433.7M COO NBIX: −$110.3M, −$101.3M, $76.6M, $132.3M, $217.6M, $233.1M, $322.9M, $361.6M, $557.2M, $748.7M NBIX BMRN: −$376.2M, −$208.0M, −$124.4M, −$96.8M, −$28.9M, $209.0M, $54.9M, $62.6M, $487.4M, $725.0M BMRN ILMN: $519.0M, $565.0M, $846.0M, $842.0M, $891.0M, $337.0M, $106.0M, $283.0M, $709.0M, $931.0M ILMN XRAY: $438.4M, $457.6M, $317.0M, $516.0M, $562.0M, $515.0M, $368.0M, $228.0M, $281.0M, $104.0M XRAY IDXX: $274.2M, $298.9M, $284.3M, $304.2M, $541.1M, $636.0M, $394.1M, $772.9M, $808.1M, $1.1B IDXX PRGO: $548.7M, $610.3M, $490.4M, $250.1M, $465.8M, $4.2M, $210.9M, $303.8M, $244.6M, $145.1M PRGO
PRGO is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$376.2M to $1.1B. A gap is a year with no number.

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

−735.3% 27.5% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ALGN: 16.4%, 16.5%, 16.9%, 24.8%, 20.5%, 19.5%, 7.4%, 15.7%, 15.6%, 12.2% ALGN MTD: 13.4%, 14.3%, 14.4%, 16.8%, 20.5%, 21.6%, 18.8%, 22.7%, 22.3%, 21.1% MTD CRL: 15.6%, 12.7%, 13.3%, 13.0%, 13.0%, 15.0%, 7.4%, 8.8%, 12.4%, 12.9% CRL COO: 18.2%, 21.8%, 18.8%, 15.9%, 7.2%, 17.9%, 13.6%, 6.0%, 7.4%, 10.6% COO NBIX: −735.3%, −62.7%, 17.0%, 16.8%, 20.8%, 20.6%, 21.7%, 19.2%, 23.7%, 26.2% NBIX BMRN: −33.7%, −15.8%, −8.3%, −5.7%, −1.6%, 11.3%, 2.6%, 2.6%, 17.1%, 22.5% BMRN ILMN: 21.6%, 20.5%, 25.4%, 23.8%, 27.5%, 7.4%, 2.3%, 6.3%, 16.2%, 21.4% ILMN XRAY: 11.7%, 11.5%, 8.0%, 12.8%, 16.8%, 12.2%, 9.4%, 5.8%, 7.4%, 2.8% XRAY IDXX: 15.4%, 15.2%, 12.8%, 12.6%, 20.0%, 19.8%, 11.7%, 21.1%, 20.7%, 24.6% IDXX PRGO: 10.4%, 12.3%, 10.4%, 6.5%, 11.4%, 0.1%, 4.7%, 6.5%, 5.6%, 3.4% PRGO
PRGO is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −735.3% to 27.5%. A gap is a year with no number.

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

−67.4% 133.3% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ALGN: 19.0%, 20.0%, 31.9%, 32.9%, 54.9%, 21.3%, 10.0%, 12.3%, 10.9%, 10.1% ALGN MTD: 88.4%, 68.7%, 86.9%, 133.3%, n/m, n/m, n/m, n/m, n/m, n/m MTD CRL: 18.5%, 11.8%, 17.2%, 15.4%, 17.2%, 15.4%, 16.3%, 13.2%, 0.6%, −4.6% CRL COO: 10.2%, 11.7%, 4.2%, 12.9%, 6.2%, 42.4%, 5.4%, 3.9%, 4.9%, 4.6% COO NBIX: −44.8%, −38.3%, 4.4%, 5.8%, 36.2%, 6.5%, 9.0%, 11.2%, 13.2%, 14.7% NBIX BMRN: −22.8%, −4.2%, −2.6%, −0.8%, 20.8%, −1.5%, 3.1%, 3.4%, 7.5%, 5.7% BMRN ILMN: 21.1%, 26.4%, 22.0%, 21.7%, 14.0%, 7.1%, −66.7%, −20.2%, −51.5%, 31.2% ILMN XRAY: 5.3%, −23.4%, −19.7%, 5.0%, −1.5%, 8.2%, −24.9%, −4.0%, −46.9%, −44.7% XRAY IDXX: n/m, n/m, n/m, n/m, 92.0%, 107.9%, 111.6%, 56.9%, 55.7%, 66.0% IDXX PRGO: −67.4%, 1.9%, 2.3%, 2.5%, −2.9%, −1.3%, −2.9%, −0.3%, −4.0%, −48.6% PRGO
PRGO is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −67.4% to 133.3%. A gap is a year with no number. A ring marks where a line starts: IDXX has no earlier 10-K here.

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

0.09 9.81 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 MTD: 2.06, 1.79, 1.75, 3.07, 4.72, 9.81, n/m, n/m, n/m, n/m MTD CRL: 1.41, 1.04, 1.22, 1.15, 0.93, 1.05, 0.91, 0.74, 0.65, 0.68 CRL COO: 0.57, 0.37, 0.61, 0.50, 0.47, 0.21, 0.38, 0.34, 0.32, 0.30 COO BMRN: -, -, -, -, -, -, -, -, -, 0.10 BMRN ILMN: 0.48, 0.43, 0.22, 0.25, 0.25, 0.09, 0.30, 0.26, 0.84, 0.73 ILMN XRAY: 0.19, 0.25, 0.32, 0.28, 0.46, 0.42, 0.52, 0.65, 1.12, 1.76 XRAY IDXX: n/m, n/m, n/m, 3.94, 1.44, 1.23, 1.26, 0.47, 0.39, 0.28 IDXX PRGO: 0.97, 0.54, 0.57, 0.58, 0.63, 0.68, 0.85, 0.85, 0.84, 1.24 PRGO
PRGO is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 0.09 to 9.81. A gap is a year with no number. A ring marks where a line starts: BMRN, IDXX have no earlier 10-K here.
CompanyFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
PRGO Dec 0.970.540.570.580.630.680.850.850.841.24
ALGN Dec ----------
MTD Dec 2.061.791.753.074.729.81n/mn/mn/mn/m
CRL Dec 1.411.041.221.150.931.050.910.740.650.68
COO Oct 0.570.370.610.500.470.210.380.340.320.30
NBIX Dec ----------
BMRN Dec ---------0.10
ILMN Dec 0.480.430.220.250.250.090.300.260.840.73
XRAY Dec 0.190.250.320.280.460.420.520.651.121.76
IDXX Dec n/mn/mn/m3.941.441.231.260.470.390.28
Peer median0.570.430.610.830.700.740.520.470.650.49

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

−$28.01 $42.05 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ALGN: $2.33, $2.83, $4.92, $5.53, $22.41, $9.69, $4.61, $5.81, $5.62, $5.65 ALGN MTD: $14.22, $14.24, $19.88, $22.47, $24.91, $32.78, $38.41, $35.90, $40.48, $42.05 MTD CRL: $3.23, $2.54, $4.62, $5.07, $7.20, $7.60, $9.48, $9.22, $0.20, −$2.91 CRL COO: $1.40, $1.88, $0.70, $2.33, $1.20, $14.79, $1.94, $1.48, $1.96, $1.87 COO NBIX: −$1.63, −$1.62, $0.22, $0.39, $4.16, $0.92, $1.56, $2.47, $3.29, $4.67 NBIX BMRN: −$3.81, −$0.67, −$0.44, −$0.13, $4.50, −$0.35, $0.75, $0.87, $2.21, $1.80 BMRN ILMN: $3.07, $4.92, $5.56, $6.74, $4.45, $5.04, −$28.00, −$7.34, −$7.69, $5.45 ILMN XRAY: $1.94, −$6.76, −$4.51, $1.14, −$0.33, $1.87, −$4.41, −$0.62, −$4.48, −$3.00 XRAY IDXX: $2.44, $2.94, $4.26, $4.89, $6.71, $8.60, $8.03, $10.06, $10.67, $13.08 IDXX PRGO: −$28.01, $0.84, $0.95, $1.07, −$1.19, −$0.52, −$1.04, −$0.09, −$1.25, −$10.29 PRGO
PRGO is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$28.01 to $42.05. A gap is a year with no number.

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out PRGO and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more

Sources

Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.

Also

Financials: PRGO's own statements, year by year. Compare: the whole peer group on one page.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PRGO/export.csv") into a cell.

Next:Industry numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.